Alan X. Ji

761 total citations
13 papers, 140 citations indexed

About

Alan X. Ji is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alan X. Ji has authored 13 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Nephrology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alan X. Ji's work include Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Parathyroid Disorders and Treatments (6 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Alan X. Ji is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Parathyroid Disorders and Treatments (6 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Alan X. Ji collaborates with scholars based in United States, Canada and Italy. Alan X. Ji's co-authors include Gilbert G. Privé, Tine Nielsen, John L. Rubinstein, Samir Benlekbir, Uma Sinha, Daniel P. Judge, Paul Wong, Isabella A. Graef, P. Wong and Mandar A. Aras and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Alan X. Ji

11 papers receiving 140 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan X. Ji United States 4 124 20 20 14 13 13 140
Marie Christine Moutty Germany 4 122 1.0× 17 0.8× 15 0.8× 12 0.9× 11 0.8× 4 150
Tiffany A. Freed United States 6 144 1.2× 17 0.8× 27 1.4× 15 1.1× 12 0.9× 8 184
Kellie Dean Ireland 7 159 1.3× 26 1.3× 9 0.5× 15 1.1× 42 3.2× 15 192
Eugenia Cisneros‐Barroso Spain 8 138 1.1× 12 0.6× 18 0.9× 41 2.9× 8 0.6× 27 157
M. Hirosawa Japan 5 144 1.2× 20 1.0× 23 1.1× 30 2.1× 15 1.2× 6 185
Annie Lin United States 9 119 1.0× 29 1.4× 13 0.7× 12 0.9× 25 1.9× 10 200
Liam Gaul United Kingdom 3 213 1.7× 15 0.8× 7 0.3× 25 1.8× 15 1.2× 3 247
Roshan K. Sriram Canada 4 49 0.4× 13 0.7× 26 1.3× 12 0.9× 8 0.6× 5 77
Franziska Ottens Germany 6 151 1.2× 9 0.5× 25 1.3× 13 0.9× 10 0.8× 7 196
Christopher Nardone United States 4 107 0.9× 25 1.3× 21 1.1× 9 0.6× 12 0.9× 8 141

Countries citing papers authored by Alan X. Ji

Since Specialization
Citations

This map shows the geographic impact of Alan X. Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan X. Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan X. Ji more than expected).

Fields of papers citing papers by Alan X. Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan X. Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan X. Ji. The network helps show where Alan X. Ji may publish in the future.

Co-authorship network of co-authors of Alan X. Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Alan X. Ji. A scholar is included among the top collaborators of Alan X. Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan X. Ji. Alan X. Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Masri, Ahmad, Mandar A. Aras, Daniel Jacoby, et al.. (2025). Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up. Journal of Cardiac Failure. 31(8). 1354–1359. 2 indexed citations
2.
Davis, Margot K., Kevin Alexander, Amrut V. Ambardekar, et al.. (2025). ACORAMIDIS IMPROVES SERUM TTR LEVELS IN PATIENTS WITH WILD-TYPE OR VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. Journal of the American College of Cardiology. 85(12). 1663–1663.
3.
Ji, Alan X., Andreas Betz, & Uma Sinha. (2025). Differential Binding Affinities and Kinetics of Transthyretin Stabilizers. Journal of Cardiovascular Pharmacology. 86(2). 204–209.
4.
Rath, D., Dominic Devost, Darlaine Pétrin, et al.. (2024). Structure and dynamics of a pentameric KCTD5/CUL3/Gβγ E3 ubiquitin ligase complex. Proceedings of the National Academy of Sciences. 121(17). e2315018121–e2315018121. 7 indexed citations
5.
Masri, Ahmad, Mandar A. Aras, Rodney H. Falk, et al.. (2024). Long-term Safety And Tolerability Of Acoramidis (AG10) In Symptomatic Transthyretin Amyloid Cardiomyopathy: 4-year Update From An Ongoing, Phase 2, Open-label Extension Study. Journal of Cardiac Failure. 30(1). 221–221. 3 indexed citations
6.
Maurer, Matthew J., Francesco Cappelli, Pablo García‐Pavía, et al.. (2024). Increase in serum TTR levels observed with acoramidis treatment in patients with transthyretin amyloid cardiomyopathy (ATTR-CM): insights from ATTRibute-CM and its open-label extension. European Heart Journal. 45(Supplement_1). 1 indexed citations
7.
Hendren, Nicholas, James A. de Lemos, Jarett D. Berry, et al.. (2024). Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I TTR carriers in the general population. Amyloid. 31(2). 124–131. 4 indexed citations
8.
9.
Masri, Ahmad, Mandar A. Aras, Rodney H. Falk, et al.. (2022). LONG-TERM SAFETY AND TOLERABILITY OF ACORAMIDIS (AG10) IN SYMPTOMATIC TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: UPDATED ANALYSIS FROM AN ONGOING PHASE 2 OPEN-LABEL EXTENSION STUDY. Journal of the American College of Cardiology. 79(9). 227–227. 2 indexed citations
10.
Sinha, Uma, et al.. (2022). MO040: Development of BBP-711, a small molecule inhibitor of glycolate oxidase for primary hyperoxaluria type 1 and recurrent kidney stone formers. Nephrology Dialysis Transplantation. 37(Supplement_3). 1 indexed citations
11.
Ji, Alan X., et al.. (2019). Abstract 13847: Differential Transthyretin Binding, Kinetic Stability and Additive Ex Vivo Stabilization by AG10 Compared to Tafamidis. Circulation. 1 indexed citations
12.
Ji, Alan X., et al.. (2015). Structural Insights into KCTD Protein Assembly and Cullin3 Recognition. Journal of Molecular Biology. 428(1). 92–107. 54 indexed citations
13.
Ji, Alan X. & Gilbert G. Privé. (2013). Crystal Structure of KLHL3 in Complex with Cullin3. PLoS ONE. 8(4). e60445–e60445. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Christine Moutty Breakdown of academic impact, for papers by Tiffany A. Freed Breakdown of academic impact, for papers by Kellie Dean Breakdown of academic impact, for papers by Eugenia Cisneros‐Barroso Breakdown of academic impact, for papers by M. Hirosawa Breakdown of academic impact, for papers by Annie Lin Breakdown of academic impact, for papers by Liam Gaul Breakdown of academic impact, for papers by Roshan K. Sriram Breakdown of academic impact, for papers by Franziska Ottens Breakdown of academic impact, for papers by Christopher Nardone
Rankless by CCL
2026